CollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial ResultsPRNewsWire • 03/24/22
CELLINK and CollPlant Enter a Collaboration Agreement to Explore Future Large-Scale Production of CollPlant's Regenerative Breast Implants using CELLINK's Bioprinting technologiesPRNewsWire • 02/16/22
CollPlant Announces Publication Highlighting its rhCollagen-based Photocurable Dermal Filler in the Plastic and Reconstructive Surgery JournalPRNewsWire • 12/02/21
CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial ResultsPRNewsWire • 11/18/21
CollPlant Announces Commercial Launch of BioInk Platform with Collink.3D™ for Use in 3D Bioprinting of Human Tissues, Scaffolds and OrgansPRNewsWire • 11/15/21
CollPlant to Present at Dawson James Small Cap Growth Conference on October 21stPRNewsWire • 10/14/21
CollPlant's rhCollagen BioInk Used by Technion Researchers to Develop 3D Bioprinted Vascularized Tissue ConstructsPRNewsWire • 10/11/21
CollPlant to Present at Fall Harvest - Best Ideas from the Buy-Side on October 5, 2021PRNewsWire • 09/30/21
CollPlant CEO Yehiel Tal to Discuss Emerging Uses of rhCollagen in Aesthetic and Regenerative Medicine at NANO.IL.2021 ConferencePRNewsWire • 09/27/21
CollPlant CEO Yehiel Tal elected to the Board of Directors of the International Society for Biofabrication (ISBF)PRNewsWire • 09/09/21
CollPlant To Present at the H.C. Wainwright Annual Global Investment Conference in SeptemberPRNewsWire • 09/07/21
CollPlant Biotechnologies Provides Business Updates and Second Quarter 2021 Financial ResultsPRNewsWire • 08/19/21
CollPlant Biotechnologies to Present on the Use of Collagen BioInk as a Platform for 3D Bioprinting of Tissues and Organs at the Biomaterials For 3D Printing WebinarPRNewsWire • 08/16/21
CollPlant Biotechnologies - A Cheap, Game-Changing Bio-Printing Platform CompanySeeking Alpha • 08/05/21
Why 3D Systems, CollPlant BioTechnologies, and Stratasys Stocks Soared TodayThe Motley Fool • 06/22/21
CollPlant Announces Effectiveness of Uplisting to the Nasdaq Global Market®; Ordinary Shares Replace ADSsPRNewsWire • 06/04/21
CollPlant Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of $14.5 MillionPRNewsWire • 05/27/21
CollPlant Announces Uplisting to the Nasdaq Global Market® and Transition to Trading of Ordinary Shares Instead of ADSsPRNewsWire • 05/25/21
CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research • 05/20/21
CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) Stock Moves -0.22%: What You Should KnowZacks Investment Research • 05/11/21
Is CollPlant Biotechnologies Ltd. Sponsored (CLGN) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 04/07/21